Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: risedronate
What it is used for
Treatment of osteoporosis. Treatment of glucocorticoid-induced osteoporosis. Preservation of bone mineral density in patients on long-term corticosteroid therapy.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 25 degrees Celsius
- Shelf lifetime is 60 Months.
Always read the label. If symptoms persist see your healthcare professional.
Light blue oval shaped film-coated tablet with "RSN" engraved on one side and "150 mg" on the other side.
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient risedronate
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What you need to know about Osteoporosis
1.2 million Australians are affected by osteoporosis, which means that their bones are fragile and at risk of fracture. A further 6.3 million people have low bone density (osteopenia), a possible precursor to osteoporosis. However, as many as 4 out of 5 people with osteoporosis don’t know that they have it and therefore don’t know that they are at risk of fracturing a bone. This is because osteoporosis is a ‘silent’ disease without obvious symptoms.
Read more on Osteoporosis Australia website
Osteoporosis - Australasian Menopause Society
Osteoporosis is a condition characterised by weakened bones that fracture easily. After menopause many women are at risk of developing osteoporosis.Peak bone mass is usually reached during a womans 20s to 30s when the skeleton has stopped growing and bones are at their strongest.The female sex hormone oestrogen plays an important role in maintaining bone strength. After menopause oestrogen levels drop and this may result in increased bone loss. The average woman loses up to 10 per cent of
Read more on Australasian Menopause Society website